REV-ERB agonist raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-07-28. Anything still debated is marked as such rather than presented as settled.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Visual inspection is not sufficient for identity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water; stock solutions use organic solvent. |
| Storage | -20°C, desiccated, protected from light | Limits hydrolysis and photodegradation. |
| Analytical method | HPLC-UV/MS | Used for identity and purity assessment. |
| Synonyms | SR9009, Stenabolic | Naming varies by supplier. |
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
=== Microfaunal interactions === The apothecia of Xanthoria parietina also host microscopic animals. Members of the rotifer genus Philodina have been observed feeding on the lichen's ascospores present on apothecial surfaces. Individual rotifers can accumulate several dozen spores, and when ingesting 20 or more spores, about 15% remain viable and capable of germination after excretion. These findings indicate that rotifers may act as dispersal vectors, dislodging and releasing viable spores in new locations.
== Deaths == 3 January – Derek Draper, 56, lobbyist and political adviser. 15 January – James Masih Shera, 77, Pakistani-born British politician and educationist. 17 January – Sir Tony Lloyd, 73, British politician, MP (1983–2012, since 2017) and mayor of Greater Manchester (2015–2017), leukemia. 19 January – Sir Graham Bright, 81, British politician, MP (1979–1997) and Cambridgeshire police and crime commissioner (2012–2016). 20 January – John Tomlinson, Baron Tomlinson, 84, British politician, MP (1974–1979) and MEP (1984–1999). 6 February – Shreela Flather, Baroness Flather, 89, British-Indian politician, Life peer (since 1990). 23 February – Ronnie Campbell, 80, British politician, MP (1987–2019). 25 February – Patrick Cormack, Baron Cormack, 84, British politician, MP (1970–2010) and member of the House of Lords (since 2010). (death announced on this date) 26 February – Jacob Rothschild, 4th Baron Rothschild, 87, British investment banker and peer, member of the House of Lords (1991–1999). 29 February – Ruth Henig, Baroness Henig, 80, historian and politician, member of the House of Lords (since 2004), Deputy Speaker of the House of Lords (since 2018). 8 March – Tommy McAvoy, Baron McAvoy, 80, British politician, MP (1987–2010) and member of the House of Lords (since 2010). (death announced on this date) 6 April – Doug Hoyle, Baron Hoyle, 98, British politician, MP (1974–1979, 1981–1983) and member of the House of Lords (1997–2023). 10 April – Richard Rosser, Baron Rosser, 79, British trade unionist and politician, member of the House of Lords (since 2004).
Freeze-drying, also known as freeze-casting or ice-templating, offers an alternative to the high temperature and high-pressure requirements of supercritical drying. Additionally, freeze-drying offers more control of the solid structure development by controlling the ice crystal growth during freezing. In this method, a colloidal dispersion of the aerogel precursors is frozen, with the liquid component freezing into different morphologies depending on a variety of factors such as the precursor concentration, type of liquid, temperature of freezing, and freezing container. As this liquid freezes, the solid precursor molecules are forced into the spaces between the growing crystals. Once completely frozen, the frozen liquid is sublimed into a gas through lyophilization, which removes much of the capillary forces, as was observed in supercritical drying. Though typically classified as a "cryogel", aerogels produced through freeze-drying often experience some shrinkage and cracking while also producing a non-homogenous aerogel framework. This often leads to freeze-drying being used for the creation of aerogel powders or as a framework for composite aerogels.
Sources: en.wikipedia.org
The Chinese People's Armed Police Coast Guard Bureau, also abbreviated as China Coast Guard is the agency for maritime search and rescue and law enforcement in the territorial waters of the People's Republic of China. The China Coast Guard was formerly the maritime branch of the People's Armed Police (PAP) Border Security Force under the Ministry of Public Security until 2013. In March 2013, China announced it would form a unified Coast Guard commanded by the State Oceanic Administration. This renewed Coast Guard has been in operation since July 2013. As of 1 July 2018, the China Coast Guard was transferred from civilian control of the State Council and the State Oceanic Administration, to the People's Armed Police, ultimately placing it under the command of the Central Military Commission (CMC). According to Joel Wuthnow of the Institute for National Strategic Studies, the Coast Guard Command within the People's Armed Police possibly is of Corps Leader Grade, led by a Commandant who usually holds the rank of major general. In June 2018, China Coast Guard was granted maritime rights and law enforcement akin civilian law enforcement agencies in order to carry out contrast of illegal activities, keep peace and order, as well as safeguarding security at sea, when performing duties related to the use of marine resources, protection of marine environment, regulation of fishery, and anti-smuggling. There are currently 3 regional bureaus:
Arjo is a global medical technology company with an annual turnover of approximately €700 million, and 4,200 employees, serving the needs of acute and long-term care. The company produces medical equipment for patient handling and hygiene, medical beds and pressure ulcer prevention, wound healing, DVT & VTE prevention, disinfection and diagnostics
Storing food below or above the "danger zone" can effectively limit the production of toxins. For storing leftovers, the food must be put in shallow containers for quick cooling and must be refrigerated within two hours. When food is reheated, it must reach an internal temperature of 165 °F (74 °C) or until hot or steaming to kill bacteria.
== Overview == The first observation of cellular structures resulting from the freezing of water goes back over a century, but the first reported instance of freeze-casting, in the modern sense, was in 1954 when Maxwell et al. attempted to fabricate turbosupercharger blades out of refractory powders. They froze extremely thick slips of titanium carbide, producing near-net-shape castings that were easy to sinter and machine. The goal of this work, however, was to make dense ceramics. It was not until 2001, when Fukasawa et al. created directionally porous alumina castings, that the idea of using freeze-casting as a means of creating novel porous structures really took hold. Since that time, research has grown considerably with hundreds of papers coming out within the last decade. The principles of freeze casting are applicable to a broad range of combinations of particles and suspension media. Water is by far the most commonly used suspension media, and by freeze drying is readily conducive to the step of sublimation that is necessary for the success of freeze-casting processes. Due to the high level of control and broad range of possible porous microstructures that freeze-casting can produce, the technique has been adopted in disparate fields such as tissue scaffolds, photonics, metal-matrix composites, dentistry, materials science, and even food science. There are three possible end results to uni-directionally freezing a suspension of particles. First, the ice-growth proceeds as a planar front, pushing particles in front like a bulldozer pushes a pile of rocks.
Sources: en.wikipedia.org
Ossuaries were used for interring human skeletal remains by Second Temple Jews and early Christians. Promession is a method of freeze drying human remains before burial to increase the rate of decomposition. Resomation accelerates disposal through the process of alkaline hydrolysis. Sky burial places the body on a mountaintop, where it decomposes in the elements or is scavenged by carrion eaters, particularly vultures.
==== Electronic Health Records ==== Sharing their electronic health records with people who have T2D helps them to reduce their blood sugar levels. It is a way of helping people understand their own health condition and involving them actively in its management.
== Further reading == Laughlin, Robert B. (June 2009). "In Situ Leach (ISL) Mining of Uranium" (PDF). Introduction to the Physics of Energy PH240 - Fall 2010. Stanford University. Retrieved 2024-02-03.
Sources: en.wikipedia.org
Liquid chromatography with mass spectrometry is a common approach. Ultraviolet detection and nuclear magnetic resonance can support identification when suitable standards are available.
The solid is generally kept cold, dry, and protected from light. Solutions are often frozen in single-use aliquots to reduce repeated freeze-thaw cycles.
It indicates a material sold for laboratory study, not for human use. The label does not guarantee pharmaceutical purity, sterility, or regulatory approval.
It is a synthetic REV-ERB agonist used mainly in preclinical research. It is not an approved medicine for human use.